JENNELLE GUIOD: Open Payments
NPI 1154094530 · PLYMOUTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 27 payments from 9 companies in 2025. Trend: 2023 $42 · 2024 $619 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $305 |
| ABBVIE INC. | 9 | $151 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Gilead Sciences, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $45 |
| Lundbeck LLC | 1 | $30 |
| Novo Nordisk Inc | 1 | $26 |
| Indivior Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $18 |
Products named: BREZTRI, AIRSUPRA, VRAYLAR, UBRELVY, QULIPTA, REXULTI, Ozempic, TRELEGY ELLIPTA.
Industry payments across NH — which companies pay providers there.
